Puniska Healthcare Revenue and Competitors
Estimated Revenue & Valuation
- Puniska Healthcare's estimated annual revenue is currently $17M per year.
- Puniska Healthcare's estimated revenue per employee is $100,500
Employee Data
- Puniska Healthcare has 169 Employees.
- Puniska Healthcare grew their employee count by -11% last year.
Puniska Healthcare's People
Name | Title | Email/Phone |
---|
Puniska Healthcare Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $56.6M | 563 | 21% | N/A | N/A |
#2 | $15.6M | 155 | 28% | N/A | N/A |
#3 | $17M | 169 | -11% | N/A | N/A |
#4 | $13.2M | 131 | 8% | N/A | N/A |
#5 | $19.6M | 195 | 10% | N/A | N/A |
#6 | $23.5M | 234 | 7% | N/A | N/A |
#7 | $5.3M | 53 | 0% | N/A | N/A |
#8 | $13M | 129 | -25% | N/A | N/A |
#9 | $20.5M | 204 | 11% | N/A | N/A |
#10 | $11.7M | 116 | 6% | N/A | N/A |
What Is Puniska Healthcare?
Puniska Healthcare is a new age pharmaceutical company, part of Puniska group, based out of Ahmedabad, India. It has been founded by Mr. Kalpesh Patel after selling his majority stake in a $300 million injectable business. Puniska is coming up with a state of the art Injectable manufacturing unit 20 kms away from Ahmedabad city. It will invest around $50 million in the first phase and the unit will be operational by year 2020. The facility will be compliant to highest regulated bodies such as US FDA and UK MHRA.
keywords:N/AN/A
Total Funding
169
Number of Employees
$17M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Puniska Healthcare News
Some companies that have lined up investment intentions in the pharmaceuticals sector are Puniska Healthcare, Alembic Pharmaceuticals, ...
Some companies that have lined up investment intentions in the pharmaceuticals sector are Puniska Healthcare, Alembic Pharmaceuticals, ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.2M | 169 | 4% | N/A |
#2 | $13.6M | 170 | 7% | N/A |
#3 | $13.6M | 171 | 50% | N/A |
#4 | $26.6M | 173 | N/A | N/A |
#5 | $13.9M | 174 | 9% | N/A |